Registry for resistant nephrotic syndrome in children
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tracks children with nephrotic syndrome whose kidney disease does not respond to usual treatments. It aims to collect information and samples to better understand resistant forms of the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child's nephrotic syndrome hasn't gotten better with standard treatments like steroids.
- A urine test shows a high amount of protein (protein-to-creatinine ratio over 1.0 grams per gram).
- Kidney function is still fairly good (eGFR above 30).
- A kidney biopsy or genetic test has confirmed the cause of nephrotic syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children newly diagnosed with nephrotic syndrome to understand how genes and proteins in the blood might predict the disease's course and response to treatment. By collecting samples, researchers hope to find markers that could guide better, more personalized care for future patients.
This trial sets up a tracking system (a registry) for people with nephrotic syndrome, to learn how the condition behaves in real life. It may help by improving how future care and studies are planned for patients with similar disease patterns.
This study looks at children’s experiences and understanding of nephrotic syndrome using questionnaires. It aims to learn what helps families and children, which could improve care over time.
This trial collects medical data and blood/urine samples from patients with minimal change disease or focal segmental glomerulosclerosis (FSGS) to better understand how the immune system damages kidney cells.
This study creates a registry to collect health information from people with rare kidney diseases. It aims to improve understanding and future treatments by tracking patient experiences.
This pilot study tests a device that stimulates nerves in the ear to help children with steroid-resistant nephrotic syndrome. It may improve urine protein and kidney-related outcomes for kids whose standard steroid treatment does not work.
Hear when a new Focal Segmental Glomerulosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.